SinomedTrip
Back to all articles

Research Breakthrough

6 articles tagged with Research Breakthrough

World-First Trial: PUMCH Proves New Drug Combination Nearly Doubles Response Rates in Aplastic AnemiaHospital News
· SinomedTrip Team

World-First Trial: PUMCH Proves New Drug Combination Nearly Doubles Response Rates in Aplastic Anemia

PUMCH's hematology team published the first-ever randomized trial showing luspatercept plus cyclosporine achieves 79% response rates in non-transfusion-dependent aplastic anemia — nearly double the standard treatment, especially in elderly patients.

Read More
PUMCH Maps the 'Culprit Cells' Behind Heart Attacks — Published in Nature CommunicationsHospital News
· SinomedTrip Team

PUMCH Maps the 'Culprit Cells' Behind Heart Attacks — Published in Nature Communications

PUMCH's vascular surgery team co-led a 169-patient study identifying two stem cell subtypes in arterial fat tissue that cause atherosclerotic plaques to rupture — the mechanism behind most heart attacks and strokes.

Read More
Not All Cervical Cancers Are Equal: PUMCH Research Shows Why Immunotherapy Works for Some Patients but Not OthersHospital News
· SinomedTrip Team

Not All Cervical Cancers Are Equal: PUMCH Research Shows Why Immunotherapy Works for Some Patients but Not Others

PUMCH's gynecologic oncology team published research revealing that cervical cancer subtypes have fundamentally different immune environments — explaining why PD-1 inhibitors work well for squamous cell carcinoma but fail in adenocarcinoma and neuroendocrine types.

Read More
No Stitches Needed: Tangdu Hospital's 3D-Printed Patch Seals Intestinal Wounds and Prevents LeakageHospital News
· SinomedTrip Team

No Stitches Needed: Tangdu Hospital's 3D-Printed Patch Seals Intestinal Wounds and Prevents Leakage

Researchers at Tangdu Hospital published a breakthrough in Theranostics — a 3D-printed asymmetric bioadhesive patch that repairs intestinal tissue without sutures, prevents the deadly complication of anastomotic leakage, and blocks post-surgical adhesions.

Read More
China's First Homegrown ALS Gene Therapy Achieves 69% Protein Reduction — Published in Nature MedicineHospital News
· SinomedTrip Team

China's First Homegrown ALS Gene Therapy Achieves 69% Protein Reduction — Published in Nature Medicine

Beijing Tiantan Hospital's neurology team developed RAG-17, China's first domestically developed siRNA drug for ALS, which reduced toxic SOD1 protein by up to 69% in a Phase 1 trial — results published in Nature Medicine.

Read More
From 'Heart vs. Brain' to 'Heart and Brain Together': PUMCH Publishes Landmark Evidence on Infective Endocarditis SurgeryHospital News
· SinomedTrip Team

From 'Heart vs. Brain' to 'Heart and Brain Together': PUMCH Publishes Landmark Evidence on Infective Endocarditis Surgery

Peking Union Medical College Hospital's cardiac surgery team published high-level evidence in JAHA resolving a decades-old clinical dilemma — when to operate on infective endocarditis patients with brain complications.

Read More